Commentary

Don't tell patients estrogens are "bad"

In vitro fertilization and preimplantation genetic testing should be offered


 

"WHAT IS THE GYNECOLOGIST'S ROLE IN THE CARE OF BRCA PREVIVORS?"
ROBERT L. BARBIERI, MD (EDITORIAL, SEPTEMBER 2013)

Young women with a BRCA mutation need not pass it to their offspring

One consideration that wasn't mentioned in Dr. Barbieri's editorial is the possibility that a woman with a BRCA mutation will pass it to her offspring. Any patient with such a mutation who has not yet completed childbearing should be advised that, with in vitro fertilization and preimplantation genetic diagnosis, we now have the capabiity to break this familial curse.

Mark Perloe, MD
Atlanta, Georgia

DR. BARBIERI RESPONDS

I agree with Dr. Perloe. I neglected to mention that, for women who are BRCA carriers who are planning a pregnancy, consultation with a fertility specialist to explore the use of assisted reproductive technology and preimplantation genetic testing is an important aspect of their health care.

WE WANT TO HEAR FROM YOU. Tell us what you think.

Recommended Reading

In young hysterectomized women, does unopposed estrogen therapy increase overall survival?
MDedge ObGyn
Bone mineral density identifies fracture risk in women over 65
MDedge ObGyn
In the hormone therapy fight, bioidenticals come out swinging
MDedge ObGyn
Breast cancer hormone therapy may affect cognitive function
MDedge ObGyn
Osteoporosis treatment and breast cancer prevention: Two goals, one treatment?
MDedge ObGyn
Hormone therapy’s protection against endometrial cancer persists in Women’s Health Initiative follow-up study
MDedge ObGyn
Screening yields long-term reduction in CRC mortality
MDedge ObGyn
STOP enforcing a 5-year rule for menopausal hormone therapy
MDedge ObGyn
FDA rejects flibanserin for low libido in women
MDedge ObGyn
No survival benefit to bisphosphonate in chemoresistant breast cancer
MDedge ObGyn

Related Articles